Assetmark »

Teva Pharmaceutical-sp shares owned by Assetmark

Quarter-by-quarter ownership of Teva Pharmaceutical-sp (TEVJF) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Teva Pharmaceutical-sp

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical-sp held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical-sp by Assetmark

Quarter filed Position value Share count Share price at filing
2026-09-30 $3.5M 89k 39.60

More positions owned by Assetmark

Vanguard World Mrngstr Mega Cap (MGK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard World Mrngstr Val Etf (MGV)
NVIDIA Corporation (NVDA)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds MRNGSTR SML CP V (VBR)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Mrngstr Md Cp Va (VOE)
Ishares Core Msci Emkt (IEMG)
Spdr Series Trust ST STR PR SP1500 (SPTM)
Meta Platforms Cl A (META)
Vanguard Index Fds MRNGSTR MD CP GR (VOT)

View all positions for Assetmark

Top funds holding Teva Pharmaceutical-sp

Assenagon Asset Management
Vontobel Holding
Hennion & Walsh Asset Management
Bourgeon Capital Management
IFM Investors Pty
Continental Advisors
Y-Intercept
Sterling Capital Management
Burford Brothers
IFP Advisors
Oak Harvest Investment Services
Sumitomo Mitsui Asset Management Company
Assetmark
KBC Group NV
Sowell Financial Services

View all funds holding Teva Pharmaceutical-sp